Arkolith/Insider Trading/LCTX/Form 4

Culley Brian M

President and CEO, DirectorLineage Cell Therapeutics, Inc. (LCTX) · full profile →Form 4 · filed Apr 4, 2022
Net Buying
Open-Market Buys
$10K
Open-Market Sells
$0
Net Open-Market Flow
$10K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2022Buy(P)6K$1.53$10K98K
Mar 31, 2022Tax withholding(F)5K$1.54$8K91K
Mar 31, 2022Option exercise(M)15K——97K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 31, 2022Option exercise(M)15K—$015K

Transaction Codes

P
Open-market purchase
F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-009000) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML